Adalimumab mitigates ovarian ischemia–reperfusion injury in rats by regulating oxidative stress, apoptosis and resolution of inflammation
article
OA: green
CC0
⤵ 1 in-corpus citation
Abstract
AIM: Ovarian torsion is a rare but an important reason of acute lower abdominal pain in women and associated with serious morbidity and mortality, if not treated promptly. The aim of this study was to evaluate the effects of an antitumor necrosis factor-α antibody on ovarian torsion in a rat model of ischemia-reperfusion (I/R) injury. METHODS: Forty female Wistar Albino rats were used in the present study. The rats were randomly divided into four groups: group I (sham), group II (I/R), group III (I/R + isotonic saline) and group IV (I/R + adalimumab). The I/R model was induced by torsion of both ovaries. Immunohistochemical staining for interleukin-1β (IL-1β), nuclear factor-κB (NF-κB), and inducible nitric oxide synthase was performed. Tissue and serum oxidative stress markers in conjunction with apoptotic index (AI) with the terminal deoxynucleotidyl transferase dUTP nick end labeling method were also calculated. RESULTS: Tissue total oxidant status, oxidative stress index and nitric oxide values were significantly decreased, and tissue total antioxidant status was found to be increased in group IV. Inflammation, vascular congestion and hemorrhagia were significantly lower in adalimumab-treated group. Serum oxidative stress markers and tissue malondialdehyde levels did not differ in study groups. The AI was significantly increased in groups 2 and 3. Adalimumab treatment significantly decreased the AI. CONCLUSION: Adalimumab therapy in rats attenuated I/R induced ovarian injury, possibly suppressing inflammation, inhibiting oxidative stress, and altering apoptotic pathways.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
Cited by (1)
References (35)
- Increased Expression of Interleukin 37 in the Eutopic and Ectopic Endometrium of Patients With Ovarian Endometriosis via openalex
- doi:10.1016/s0021-9258(19)52451-6 via openalex
- doi:10.4196/kjpp.2014.18.4.321 via openalex
- doi:10.1016/j.clinbiochem.2016.02.005 via openalex
- doi:10.1016/j.ejogrb.2014.08.001 via openalex
- doi:10.1111/j.1464-410x.2006.06321.x via openalex
- doi:10.1016/j.cytogfr.2011.10.001 via openalex
- doi:10.1136/annrheumdis-2012-202220 via openalex
- doi:10.1016/j.bbamcr.2011.01.034 via openalex
- doi:10.1016/j.jpedsurg.2012.03.053 via openalex
- doi:10.1007/s00210-012-0729-z via openalex
- doi:10.1016/j.juro.2012.01.029 via openalex
- doi:10.1165/ajrcmb.17.1.f132 via openalex
- doi:10.1016/s0022-5347(05)68626-0 via openalex
- doi:10.1177/0748233711427056 via openalex
- doi:10.1111/j.1745-7254.2006.00287.x via openalex
- doi:10.1016/j.jss.2013.04.019 via openalex
- doi:10.1097/mpa.0b013e3181dec1a6 via openalex
- doi:10.1021/jf400227u via openalex
- doi:10.1186/1758-5996-6-130 via openalex
- doi:10.3906/sag-1207-108 via openalex
- doi:10.1161/01.res.82.5.576 via openalex
- doi:10.17219/acem/33250 via openalex
- doi:10.1016/j.jpedsurg.2014.12.013 via openalex
- W2181403678 via openalex
- W2285615373 via openalex
- W2462665731 via openalex
- doi:10.1016/j.ejogrb.2010.02.006 via openalex
- doi:10.3390/ijms14036106 via openalex
- doi:10.1016/s1357-2725(96)00159-8 via openalex
- doi:10.1080/09513590.2018.1450378 via openalex
- doi:10.1155/2014/360438 via openalex
- doi:10.1080/01443615.2017.1383371 via openalex
- doi:10.1146/annurev.immunol.14.1.649 via openalex
- doi:10.4414/smw.2012.13590 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T03:41:56.425819+00:00
License: CC0
· commercial use OK